Investigating how Rnd3 affects lung cancer spread
Molecular Mechanism of Rnd3 Regulation in Lung Cancer
This study is looking at how a protein called Rnd3 affects the movement of lung cancer cells, with the goal of finding new ways to treat lung cancer, especially when it spreads to other parts of the body.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-11049050 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a protein called Rnd3 in the spread of lung cancer, particularly how it influences cancer cell movement and invasion. Researchers will examine how changes in Rnd3 levels can affect the behavior of lung cancer cells, using laboratory techniques to analyze cell migration and invasion. By uncovering the molecular mechanisms behind Rnd3's regulation, the study aims to identify new therapeutic strategies for treating lung cancer, especially in cases where it has metastasized.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with lung adenocarcinoma, particularly those with varying levels of Rnd3 expression.
Not a fit: Patients with non-lung cancers or those whose cancer has not metastasized may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve survival rates for lung cancer patients by targeting the mechanisms of metastasis.
How similar studies have performed: Previous research has shown promising results in targeting molecular pathways in cancer treatment, suggesting that this approach could also yield significant insights.
Where this research is happening
Little Rock, United States
- Univ of Arkansas for Med Scis — Little Rock, United States (Active)
Researchers
- Principal investigator: Ryan, Katie — Univ of Arkansas for Med Scis
- Study coordinator: Ryan, Katie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.